Johanna N.H. Timmer-Bonte

The First-in-Human Study of the Hydrogen Sulfate (Hyd-Sulfate) Capsule of the MEK1/2 Inhibitor AZD6244 (ARRY-142886): A Phase I Open-Label Multicenter Trial in Patients with Advanced Cancer

Udai Banerji, D. Ross Camidge, Henk M.W. Verheul et al. · Clinical Cancer Research · 2010 · 209 citations

Prevention of Chemotherapy-Induced Febrile Neutropenia by Prophylactic Antibiotics Plus or Minus Granulocyte Colony-Stimulating Factor in Small-Cell Lung Cancer: A Dutch Randomized Phase III Study

Johanna N.H. Timmer-Bonte, Theo M. de Boo, Hans J.M. Smit et al. · Journal of Clinical Oncology · 2005 · 184 citations

Chemotherapy Response Evaluation with 18F-FDG PET in Patients with Non-Small Cell Lung Cancer

Lioe‐Fee de Geus‐Oei, Erik H.F.M. van der Heijden, Eric P. Visser et al. · Journal of Nuclear Medicine · 2007 · 114 citations · Full text

Cost-Effectiveness of Adding Granulocyte Colony-Stimulating Factor to Primary Prophylaxis With Antibiotics in Small-Cell Lung Cancer

Johanna N.H. Timmer-Bonte, Eddy Adang, Hans J.M. Smit et al. · Journal of Clinical Oncology · 2006 · 85 citations · Full text

Phase Ib study of NGR–hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours

Vanesa Gregorc, Armando Santoro, E. Bennicelli et al. · British Journal of Cancer · 2009 · 84 citations · Full text